SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling

Hormone and Metabolic Research

Volumn 35, Issue 3, 2003, Pages 169-177

  Ridderstrale M ^a,f   Amstrup, J ^b   Hilton, D J ^c   Billestrup, N ^b,d   Tornqvist, H ^a,b,e  

^a LUND UNIVERSITY   (Sweden)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d STENO DIABETES CENTER   (Denmark)

^e NOVO NORDISK A S   (Denmark)

^f Malmö University Hospital   (Sweden)

Author keywords

A293 Cells; Lipogenesis; Phosphorylation; STAT 5; Transient Expression

Indexed keywords

CYTOKINE INDUCIBLE SH2 PROTEIN; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; HUMAN INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; JANUS KINASE; MESSENGER RNA; PROTEIN; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; INSULIN LIKE ACTIVITY; LIPOGENESIS; MALE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REFRACTORY PERIOD; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

ADIPOCYTES; ANIMALS; CARRIER PROTEINS; DNA-BINDING PROTEINS; EMBRYO; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION; GROWTH HORMONE; HUMANS; IMMEDIATE-EARLY PROTEINS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JANUS KINASE 2; KIDNEY; LIPIDS; MALE; MILK PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOTROPIN; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TYROSINE;

ANIMALIA; JANUS;

EID: 0038292961     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39077     Document Type: Article

References (60)

1. Isaksson OGP, Edén S, Jansson JO. Mode of action of pituitary growth hormone on target cells. Ann Rev Physiol 1985; 47: 483-499
2. Press M. Growth hormone and metabolism. Diabetes Metab Rev 1988; 4: 391-414
3. Davidson M. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 1987; 8: 115-131
4. Wabitsch M, Hauner H, Heinze E, Teller W. In vitro effects of growth hormone in adipose tissue. Acta Paediatr Suppl 1994; 83: 48-53
5. Wabitsch M, Heinze E, Hauner H, Shymko RM, Teller WM, de Meyts P. Ilondo M. Biological effects of human growth hormone in rat adipocyte precursor and newly differentiated adipocytes in primary culture. Metabolism 1996; 45: 34-42
6. Edén S, Schwartz J, Kostyo JL. Effects of preincubation on the ability of rat adipocytes to bind and response to growth hormone. Endocrinology 1982; 111: 1505-1512
7. Eriksson H, Ridderstråle M, Tornqvist H. Tyrosin phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like effects of GH in primary rat adipocytes. Endocrinology 1995; 136: 5093-5101
8. Ridderstråle M, Degerman E, Tornqvist H. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J Biol Chem 1995; 270: 3471-3474
9. Souza SC, Frick GP, Yip R, Lobo RB, Tai LR, Goodman HM. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J Biol Chem 1994; 269: 30085-30088
10. Ridderstråle M, Tornqvist H. PI-3-kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem Biophys Res Commun 1994; 203: 306-310
11. Fain JN. Studies on the role of RNA and protein synthesis in the lipolytic action of growth hormone in isolated fat cells. Adv Enzyme Regul 1967; 5: 39-51
12. Fain JN, Saperstein R. The involvement of RNA synthesis and cyclic AMP in the activation of fat cell lipolysis by growth hormone and glucocorticoids. Horm Metab Res 1970; 2: 20-27
13. Campbell GS, Pang L, Miyasaka T, Saltiel AR, Carter-Su C. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J Biol Chem 1992; 267: 6074-6080
14. Winston LA, Bertics PJ. Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins. J Biol Chem 1992; 267: 4747-4751
15. Anderson NG. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes. Biochem J 1992; 284: 649-652
16. Schindler C, Darnell JE. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995; 64: 621-651
17. Carter-Su C, Schwartz J, Smit LS. Molecular mechanism of growth hormone action. Ann Rev Physiol 1996; 58: 187-207
18. Ridderstråle M, Groop L. Differential phosphorylation of Janus kinase 2, Stat5A and Stat5B in response to growth hormone in primary rat adipocytes. Mol Cell Endocrinol 2001; 183: 49-54
19. Goodman HM. Separation of early and late responses of adipose tissue to growth hormone. Endocrinology 1981; 109: 120-129
20. Schwartz Y, Yamaguchi H, Goodman HM. Growth hormone increases intracellular free calcium in rat adipocytes: correlation with actions on carbohydrate metabolism. Endocrinology 1992; 131: 772-778
21. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917-921
22. Endo TA, Masuhara M, Tokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921-924
23. Auernhammer CJ, Melmed S. The central role of OSCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest 2001; 108: 1735-1740
24. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem 1998; 273: 1285-1287
25. Favre H, Benhamou A, Finidori J, Kelly PA, Edery M. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett 1999; 453: 63-66
26. Ram PA, Waxman DJ. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by mutiple mechanisms. J Biol Chem 1999; 274: 35553-35561
27. Rodbell M. Metabolism of isolated fat cells. J Biol Chem 1964; 239: 375-380
28. Moody AJ, Stan MA, Stan M, Glieman J. A simple free fat cell bioassay for insulin. Horm Metab Res 1974; 6: 12-16
29. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-2752
30. Gorman CM, Gies D, McCray G, Huang M. The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins. Virology 1989; 171: 377-385
31. Jensen J, Serup P, Karlsen C, Nielsen TF, Madsen OD. mRNA profiling of rat islet tumors reveals nkx 6.1 as a beta-cell-specific homeodomain transcription factor. J Biol Chem 1996; 271: 18749-18758
32. Ridderstråle M, Tornqvist H. Effects of tyrosine kinase inhibitors on tyrosine phosphorylations and the insulin-like effects in response to human growth hormone in isolated rat adipocytes. Endocrinology 1996; 137: 4650-4656
33. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994; 372: 182-186
34. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, Johnson RS, Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372: 186-190
35. Sun XJ, Wang LM, Zhang YT, Yenush L, Myers MG, Glasheen E, Lane WS, Pierce JH, White MF. Role of IRS-2 in insulin and cytokine signalling. Nature 1995; 377: 173-177
36. Lavan BE, Lane WS, Lienhard GE. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 11439-11443
37. Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem 1996; 271: 29415-29421
38. Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, Bistrian BR, Smith RJ. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 1996; 137: 2880-2886
39. Yamauchi T, Kaburagi Y, Ueki K, Tsuji Y, Stark GR, Kerr IM, Tsushima T, Akanuma Y, Komuro I, Tobe K, Yazaki Y, Kadowaki T. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J Biol Chem 1998; 273: 15719-15726
40. Thirone AC, Carvalho CR, Saad MJ. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Endocrinology 1999; 140: 55-62
41. Villanueva-Peñacarrillo ML, Márquez L, González N, Díaz-Miguel M, Valverde I. Effect of GLP-1 on lipid metabolism in human adipocytes. Horm Metab Res 2001; 33: 73-77
42. Lobie PE, Mertani H, Morel G, Moralesbustos O, Norstedt G, Waters MJ. Receptor-mediated nuclear translocation of growth hormone. J Biol Chem 1994; 269: 21330-21339
43. Lobie PE, Wood TJJ, Chen CM, Waters MJ, Norstedt G. Nuclear translocation and anchorage of the growth hormone receptor. J Biol Chem 1994; 269: 31735-31746
44. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 1993; 74: 237-244
45. Johnston JA, Kawamura M, Kirken RA, Chen Y, Blake TB, Shibuya K, Ortaldo JR, Mcvicar DW, O'Shea JJ. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 1994; 370: 151-153
46. Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3 and 5 by GH. Mol Endocrinol 1996; 10: 519-533
47. Han YL, Leaman DW, Watling D, Rogers NC, Groner B, Kerr IM, Wood WI, Stark GR. Participation of JAK and STAT proteins in growth hormone-induced signaling. J Biol Chem 1996; 271: 5947-5952
48. Carter-Su C, Smit LS. Signaling via JAK tyrosine kinases: growth hormone receptor as a model system. Recent Prog Horm Res 1998; 53: 61-82
49. Zhu T, Goh EL, Lobie PE. Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. Fak is not required for Stat-mediated transcription. J Biol Chem 1998; 273: 10682-10689
50. Zhu T, Goh ELK, LeRoith D, Lobie PE. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem 1998; 273: 33864-33875
51. Silva CM, Lu H, Day RN. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. Mol Endocrinol 1996; 10: 508-518
52. Ilondo MM, Damholt AB, Cunningham BA, Wells JA, Demeyts P, Shymko RM. Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Endocrinology 1994; 134: 2397-2403
53. Bousquet C, Susini C, Melmed S. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest 1999; 104: 1277-1285
54. Bjorbaeck C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 1999; 274: 30059-30065
55. Pezet A, Favre H, Kelly PA, Edery M. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. J Biol Chem 1999; 274: 24497-24502
56. Siewert E, Muller-Esterl W, Starr R, Heinrich PC, Schaper F. Different protein turnover of interleukin-6-type cytokine signalling components. Eur J Biochem 1999; 265: 251-257
57. Sotiropoulos A, Perrotapplanat M, Dinerstein H, Pallier A, Postelvinay MC, Finidori J, Kelly PA. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology 1994; 135: 1292-1298
58. Vanderkuur JA, Wang XY, Zhang LY, Campbell GS, Allevato G, Billestrup N, Norstedt G, Carter-Su C. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J Biol Chem 1994; 269: 21709-21717
59. Frank SJ, Gilliland G, Kraft AS, Arnold CS. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 1994; 135: 2228-2239
60. Yip RG, Goodman HM. Growth hormone and dexamethasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gi alpha2 to lower density membrane fractions. Endocrinology 1999; 140: 1219-1227